INSP Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
206.7M
+3.0%
200.6M
-2.0%
204.6M
-24.0%
269.1M
+19.9%
224.5M
Cost of Revenue
28.8M
-1.0%
29.1M
+5.2%
27.7M
-23.3%
36.1M
+13.5%
31.8M
Gross Profit
177.9M
+3.7%
171.5M
-3.1%
176.9M
-24.1%
233.0M
+20.9%
192.7M
Operating Expenses
206.6M
+20.1%
172.0M
-3.4%
178.0M
-4.7%
186.9M
+2.1%
183.1M
R&D
22.2M
-10.2%
24.7M
-4.4%
25.8M
+3.5%
24.9M
+3.0%
24.2M
SG&A
184.4M
+25.2%
147.3M
-3.2%
152.2M
-6.0%
162.0M
+1.9%
158.9M
Operating Income
-28716000
-5486.8%
-514000
+54.0%
-1118000
-102.4%
46.1M
+378.1%
9.6M
EBITDA
-23576000
-677.4%
4.1M
+2.3%
4.0M
-92.0%
49.9M
+274.8%
13.3M
Net Income
-24394000
-7868.8%
314.0K
+102.8%
-11294000
-108.3%
136.1M
+1270.2%
9.9M
EPS (Basic)
$-0.84
-8500.0%
$0.01
+102.6%
$-0.39
-108.3%
$4.70
+1282.4%
$0.34
EPS (Diluted)
$-0.84
-8500.0%
$0.01
+102.6%
$-0.39
-108.5%
$4.60
+1252.9%
$0.34
Shares (Diluted)
28.9M
-0.0%
28.9M
+0.8%
28.7M
-3.1%
29.6M
+0.0%
29.6M
Inspire Medical Systems (INSP) — Financials